Immunogenicity of NVX-CoV2373 in PREVENT-19: A Phase 3, Randomized, Placebo-Controlled Trial in Adults in the United States and Mexico.

Áñez, Germán; Kotloff, Karen L; Gay, Cynthia L; Nelson, Joy; Dunbar, Haoua; Cloney-Clark, Shane; McGarry, Alice; Woo, Wayne; Cho, Iksung; Plested, Joyce S; Glenn, Gregory M; Dunkle, Lisa M

Áñez, Germán; Kotloff, Karen L; Gay, Cynthia L; Nelson, Joy; Dunbar, Haoua; Cloney-Clark, Shane; McGarry, Alice; Woo, Wayne; Cho, Iksung; Plested, Joyce S; Glenn, Gregory M; Dunkle, Lisa M.

Afiliação

Áñez G; Novavax, Inc., Gaithersburg, Maryland, USA.
Kotloff KL; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Gay CL; Institute for Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Nelson J; Novavax, Inc., Gaithersburg, Maryland, USA.
Dunbar H; Novavax, Inc., Gaithersburg, Maryland, USA.
Cloney-Clark S; Novavax, Inc., Gaithersburg, Maryland, USA.
McGarry A; Novavax, Inc., Gaithersburg, Maryland, USA.
Woo W; Novavax, Inc., Gaithersburg, Maryland, USA.
Cho I; Novavax, Inc., Gaithersburg, Maryland, USA.
Plested JS; Novavax, Inc., Gaithersburg, Maryland, USA.
Glenn GM; Novavax, Inc., Gaithersburg, Maryland, USA.
Dunkle LM; Novavax, Inc., Gaithersburg, Maryland, USA.

medRxiv ; 2023 May 11.

Article em En | MEDLINE | ID: mdl-37214968

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline País/Região como assunto: Mexico Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google